
Aeon, a Zurich-based preventive healthcare company, has acquired German blood diagnostics platform Aware Health and closed its Seed extension.
The extension brings Aeon's total Seed funding to over €12 million, building on its previous €8.2 million Seed funding raised in June 2025.
Key Takeaways
Center
Not enough sources yet on this side — a blindspot summary will appear once outlets cover the story.
Not enough sources yet on this side — a blindspot summary will appear once outlets cover the story.
Get every side of the week's biggest story in your inbox.
The acquisition and funding may impact the preventive healthcare industry and AI-powered health check-ups
No attributed perspective yet — we only show quotes grounded in analysis.
Evaluated across 1 reporting source (0% Left · 100% Center · 0% Right)
Historical editorial baseline for EU-Startups
Multi-factor accuracy index for EU-Startups and related desks based on verifiable sourcing and editorial standards.
Factuality: High 100%
Ownership: EU-Startups (Corporate)
Public conversation related to this story
Loading comments…